Have a personal or library account? Click to login
Ethosuximide for Essential Tremor: An Open-Label Trial Cover

Ethosuximide for Essential Tremor: An Open-Label Trial

Open Access
|Jul 2016

Figures & Tables

Table 1

Clinical Characteristics of Patients in the Present Series

PatientAge, SexFamily HistoryEvolution (years)ET MedicationCompleted StudyCauses of drop-out
174, F+10PropranololYes
266, M+8PrimidoneYes
380, F+5PrimidoneNoNervousness, anxiety, headache
479, F+15PropranololNoDizziness, nausea, instability
570, F+20PropranololYes
671, M+15GabapentinYes
772. M+8GabapentinYes

[i] Abbreviations: ET, Essential Tremor; F, Female; M, Male.

Table 2

Scores of the Patients who Completed the Study

PatientDay 1Day 22
TCRS 1+2TCRS 3ACCDISTCRS 1+2TCRS 3TCRS 4ACCDIS
13515887403516090141
24315922474415094440
54113788384013−180038
63917966454017097845
757151,04761611401,03764

Abbreviations: ACC, Accelerometer Data (in µV2); DIS, Bain Disability Scale; TCRS, Tremor Clinical Rating Scale.

1 Before assessments were taken before drug intake on the test day.

DOI: https://doi.org/10.5334/tohm.306 | Journal eISSN: 2160-8288
Language: English
Submitted on: Mar 9, 2016
Accepted on: May 5, 2016
Published on: Jul 13, 2016
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2016 Alexandre Gironell, Juan Marin-Lahoz, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.